Details for 2015882259
Up to date per 03.04.2026
Actions
Details for 2015882259
Deleted
European Patent
20.12.2017 A
23.12.2020 B1
10.02.2015
US
201562114304 P
A61K 31/4178 20060101AFI20200518BHEP
Owner
Tobira Therapeutics, Inc.701 Gateway Boulevard, Suite 300 South San Francisco CA 94080US
Representative
No representatives present
Inventor
LEFEBVRE, Ericc/o Tobira Therapeutics, Inc. 701 Gateway Blvd Suite 300 South San Francisco, CA 94080US